Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan 5:7:1.
doi: 10.1186/1746-1596-7-1.

Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors

Iman H Hewedi  1 , Nehal A Radwan, Lobna S Shash
Affiliations

Diagnostic value of progesterone receptor and p53 expression in uterine smooth muscle tumors

Iman H Hewedi et al. Diagn Pathol. .

Abstract

Background: The diagnosis of uterine smooth muscle tumors depends on a combination of microscopic features. However, a small number of these tumors still pose difficult diagnostic challenges.

Aim: To investigate progesterone receptor (PR) and p53 expression in leiomyomas (LMs), atypical leiomyomas (ALMs), smooth muscle tumors of uncertain malignant potential (STUMP), and leiomyosarcomas (LMSs) and to evaluate the potential utility of the selected immunohistochemical markers in differentiating these tumors.

Materials and methods: Immunohistochemical expression of PR and p53 was investigated in 41 uterine smooth muscle tumors comprising: 15 LMS, 4 STUMP, 6 ALM and 16 LM. Quantitative evaluation of PR and p53 expression was graded on a scale from 0 to 3+.

Results: Leiomyosarcomas showed reduced PR expression. All LMs as well as ALMs and STUMP were stained intensely for PR. Conversely, LMS was strongly stained with p53, while the three non-sarcomatous groups (STUMP, ALM, LM) were either entirely negative or weakly stained for p53. Regarding both PR and p53 expression, the difference between the LMS group and the three non-sarcomatous groups was highly significant (p < 0.001). Combined high PR - low p53 expression was seen in all the 26 examined cases of the non-sarcomatous group including the STUMP cases and none of the LMS cases. Therefore, it represents a "benign" profile with 100% specificity in diagnosis of a non-sarcomatous tumor.

Conclusion: Immunohistochemistry for PR and p53 is valuable as an adjunct tool to morphological assessment of problematic uterine smooth muscle tumors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
High PR expression (3+) in a leiomyoma,(PR × 400).
Figure 2
Figure 2
Atypical leiomyoma with high PR expression (3+),(PR × 400).
Figure 3
Figure 3
Smooth muscle tumor of uncertain malignant potential (STUMP) with high PR expression (3+),(PR × 400).
Figure 4
Figure 4
A leiomyosarcoma exhibits negative immunoreactivity for PR,(PR × 400).
Figure 5
Figure 5
High p53 expression (3+) in a leiomyosarcoma,(p53 × 400).
See this image and copyright information in PMC

References

    1. Zaloudek CJ, Hendrickson MR, Soslow RA. In: Blaustein's Pathology of the Female Genital Tract. 6. R. Kurman RJ, Ellenson LH, Ronnett BM, editor. Springer New York; 2011. Mesenchymal tumors of the uterus; pp. 453–527.
    1. Rammeh-Rommani S, Mokni M, Stita W, Trabelsi A, Hamissa S, Sriha B, Tahar-Yacoubi M. J Gynecol Obstet Biol Reprot. 2005. pp. 568–7. - PubMed
    1. Ünver NU, Acikalin MF, Öner Ü, Ciftci E, Ozalp SS, Colak E. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors. Arch Gynecol Obstet. 2011;284(2):483–90. doi: 10.1007/s00404-010-1690-z. - DOI - PubMed
    1. O'neill CI, Mcbride HA, Connolly LE, Mccluggage WG. Histopathology. 2007. pp. 851–8. - DOI - PubMed
    1. Gökaslan H, Turkeri L, Kavak ZN, Eren F, Sismanoglu A, Ilvan S. et al. Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors. Gynecol Obstet Invest. 2005;59:36–40. doi: 10.1159/000080933. - DOI - PubMed